Description: To carry out translational research capabilities in the area of cellular therapy for diabetes and related complications. As a national resource for isolation, purification, and transportation of live clinical-grade human cells, they are heavily relied upon for the availability of clinical grade cellular products for the transplantation of insulin-producing pancreatic cells. Improvements in specific areas include cell sorting, analysis, and imaging which have provided notable improvements to the cell isolation process and have also increased the areas of research for tissue-engineered end products.
|
|
|
Diabetes Research Institute |
$1,349 |
|
Other |
Miami,
FL
|
|
Citation
|
Source:
Appropriations Report Language - Conference
|
Reference:
108-622
|
Location:
Line 130, Page 303
|
Citation Excerpt: Somatic Cell Processing Program (Diabetes Research)
|
|
Last Modified: 16-Apr-2007
|
|